TRANSCATHETER

作品数:251被引量:775H指数:15
导出分析报告
相关领域:医药卫生更多>>
相关作者:贾红燕刘赟王斌武帅王建华更多>>
相关机构:中国人民解放军总医院中国医学科学院肿瘤医院山西医科大学第一医院复旦大学更多>>
相关期刊:更多>>
相关基金:国家自然科学基金国家教育部博士点基金国家重点基础研究发展计划北京市自然科学基金更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
A preclinical evaluation and first-in-man case for transcatheter edge-to-edge mitral valve repair using PulveClip®transcatheter repair device
《Journal of Geriatric Cardiology》2025年第2期265-269,共5页Gang-Jun ZONG Jie-Wen DENG Ke-Yu CHEN Hua WANG Fei-Fei DONG Xing-Hua SHAN Jia-Feng WANG Ni ZHU Fei LUO Peng-Fei DAI Zhi-Fu GUO Yong-Wen QIN Yuan BAI 
supported by the Cultivation of Scientific Research Project of Changhai Hospital,Shanghai,China(No.2021JCMS20);Major Topics of the Health Commission of Jiangsu Province(ZD2021020).
The prevalence of mitral regurgitation(MR)is increasingly worldwide as a consequence of improved survival and ischemic heart disease.Severe MR is associated with worse prognosis,independent of left ventricular functio...
关键词:MITRAL TRANSCATHETER PROGNOSIS 
A Novel Kyrin^(TM)Tricuspid Transcatheter Edge-to-edge Repair Device:A First-in-human Study
《Cardiology Discovery》2024年第4期323-324,共2页Da Zhu Mi Chen Junje Zhang Jing Chen Ben He Shouzheng Wang Xiangbin Pan 
supported by the National Key R&D Program of China(2022YFC2503400);the Major Science and Technology Special Plan Project of Yunnan Province(202302AA310045).
The surgical treatment of isolated tricuspid regurgitation presents a notable mortality risk,particularly in patients who are referred late.Tricuspid transcatheter edge-to-edge repair(TEER)has become a safe and effect...
关键词:MORTALITY patients MEDICAL 
Regulatory science promotes the translation of transcatheter tricuspid valve repair/replacement devices
《Regenerative Biomaterials》2024年第6期42-49,共8页Maobo Cheng Yun Xu Wei Liu Lanlan Mu Xiaoqi Lian Guobiao Gao Lei Sun 
supported by funding from the second batch(for research and translation pre-evaluation of innovative medical biomaterials)and the third batch(for research on performance and safety evaluation of innovative biomaterial medical devices)of the Chinese Drug Regulatory Science Action Plan of the National Medical Products Administration.
For patients with symptomatic and severe tricuspid regurgitation but inoperable with open surgery,transcatheter tricuspid valve intervention(TTVI)is a procedure of great clinical value.TTVI products include repair and...
关键词:transcatheter interventional products transcatheter tricuspid valve repair devices transcatheter tricuspid valve replacement devices regulatory science TRANSLATION 
Body mass index and prognostic outcomes after transcatheter aortic valve replacement:Insights from the Chinese Cardiovascular Association Database-National Transcatheter Valve Therapeutics Registry
《Chinese Medical Journal》2024年第23期2880-2882,共3页Qiong Liu Sanjay Jaiswal Qifeng Zhu Jianfang Luo Yan Wang Daxin Zhou Mao Chen Xianbao Liu Jian’an Wang 
granted by Healthy Zhejiang One Million People Cohort(No.K-20230085).
To the Editor:Transcatheter aortic valve replacement(TAVR)has witnessed a rapid global surge and emerged as a viable alternative for treating aortic stenosis patients.Obesity,a well-established risk factor for the dev...
关键词:AORTIC viable index 
Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma:a prospective,single-arm,phase II study被引量:1
《Signal Transduction and Targeted Therapy》2024年第11期5183-5192,共10页Yiwen Chen Junlei Zhang Wendi Hu Xiang Li Ke Sun Yan Shen Min Zhang Jian Wu Shunliang Gao Jun Yu Risheng Que Yun Zhang Fuchun Yang Weiliang Xia Aibin Zhang Xiaofeng Tang Xueli Bai Tingbo Liang 
supported by grants from the National Natural Science Foundation of China(No.82172859,82071916,U20A20378,and 82188102);the Joint Fund for Regional Innovation and Development of National Natural Science Foundation of China(No.U23A20462).
Evidences regarding the feasibility of transcatheter arterial chemoembolization(TACE)-based therapy for unresectable hepatocellular carcinoma(uHCC)remains limited.This study aimed to investigate the efficacy and safet...
关键词:TRANSCATHETER HEPATOCELLULAR ARTERIAL 
Transcatheter Pulmonary Valve Implantation:A State of the Art Review
《Congenital Heart Disease》2024年第5期513-533,共21页Biagio Castaldi Francesco Prati Alice Pozza Irene Cattapan Jennifer Fumanelli Domenico Sirico Giovanni Di Salvo 
Congenital heart disease(CHD)affects about 1%of live births.Among them,about 20%will undergo one or more surgical or percutaneous maneuvers on the right ventricle outflow tract or pulmonary valve.Transcatheter pulmona...
关键词:Congenital heart disease percutaneous pulmonary valve implantation MELODY sapien venus P HARMONY alterra pulsta pulmonary valve replacement 
Initial Experience in GeminiOne^(TM)Transcatheter Mitral Valve Edge-to-edge Repair Device
《Cardiology Discovery》2024年第3期250-252,共3页Da Zhu Shouzheng Wang Jinping Liu Zhenfei Fang Mao Chen Ben He Xiangbin Pan 
supported by the National Key R&D Program of China(2022YFC2503400);Major science and technology special plan project of Yunnan Province(202302AA310045);Yunnan Provincial Clinical Research Center for Cardiovascular Diseases(202102AA310002).
Transcatheter edge-to-edge repair(TEER)of the mitral valve has emerged as a standard treatment for patients with severe degenerative mitral regurgitation at high or prohibitive surgical risk.The devices approved by th...
关键词:PASCAL Mitra ABBOTT 
Thirty-day Outcomes of First-in-man Implantation of a Novel Transcatheter Edge-to-edge Mitral Repair System in Patients With Severe Mitral Regurgitation
《Cardiology Discovery》2024年第2期142-147,共6页Kai Xu Yan Wang Shaoliang Chen Xiangbin Pan Ben He Ruiyan Zhang Bin Wang Junjie Zhang Zhengbin Zhu Bin Wang Da Zhu Yaling Han 
supported by the National Key Project of Research and Development Plan during the fourteenth Five-year Plan Period(2022YFC2503400).
Objectives:The aim of this multicenter,prospective,single-arm pilot study(ClinicalTrials.gov number:NCT05040074)was to observe the procedural and 30-day results of the novel transcatheter mitral valve repair system,SQ...
关键词:Heart failure Mitral regurgitation Transcatheter mitral valve repair Transcatheter edge-to-edge repair 
First-in-human Results of the Novel Transcatheter Mitral Valve Repair System for Severe Mitral Regurgitation
《Cardiology Discovery》2024年第2期148-159,共12页Zhi-Nan Lu Yutong Ke Yingnan Bian Jing He Wenhui Wu Xinmin Liu Yang Li Ran Liu Taiyang Luo Xunan Guo Guangyuan Song 
This study is part of the China Degenerative Valve Disease II Cohort Study(China-DVD2 Study,NCT05044338);which is supported by the National Key R&D Program of China(2020YFC200801100).
Objective:To evaluate the feasibility,safety,and effectiveness of a novel edge-to-edge mitral valve repair system(the NovoClasp system)in patients with severe mitral regurgitation.Methods:In this prospective,single-ar...
关键词:Mitral valve insufficiency Transcatheter edge-to-edge repair FEASIBILITY Safety 
First-in-man Experience of a New Transcatheter Edge-to-edge Repair System Neoblazar in Patients With Severe Tricuspid Regurgitation
《Cardiology Discovery》2024年第2期160-166,共7页Xiang Chen Da Zhu Maolong Su Xu Chen Pianpian Yan Hongmei Wen Bin Wang Nianguo Dong Xiangbin Pan Yan Wang 
National Key Researchand Development Program(2022YFC2503400);Yunnan Provincial Clinical Research Center for Cardiovascular Diseases(202302AA310045).
objective:Severe tricuspid regurgitation frequently leads to increased mortality and a poor prognosis.Transcatheter edge-to-edge repair(TEER)for tricuspid valve regurgitation has been reported as a safe alternative to...
关键词:Tricuspid valve insufficiency Transcatheter edge-to-edge repair Heart failure 
检索报告 对象比较 聚类工具 使用帮助 返回顶部